EN
HI
Summary
As of 25 Oct, 2026, Fredun Pharmaceuticals stock price is ₹1368.4. During the trading session, the stock has moved between an intraday low of ₹1315.80 and an intraday high of ₹1398.90. Over the last 52 weeks, Fredun Pharmaceuticals has traded between ₹1195.20 and ₹1665.00.
The stock has recorded a trading volume of 52,749 shares,. Its Average Traded Price (ATP) is ₹1348.63, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 418 @ ₹1368.40.
Fredun Pharmaceuticals has an upper circuit limit of ₹1642.00 and a lower circuit limit of ₹1094.80. The total value traded stands at ₹7.11 CR, and the delivery percentage for the day is 47.74%.
The stock is currently traded with a market lot size of 1. Fredun Pharmaceuticals also offers a dividend yield of 0.02%.
Fredun Pharmaceuticals Share Price Chart
Fredun Pharmaceuticals Share Key Metrics
Volume
52749.00
Market Cap
2263.07 CR
LTQ@LTP
418@1368.40
ATP
1348.63
Var Margin
25.57 %
Circuit Range
1094.8-1642
Delivery %
47.74 %
Value
7.11 CR
ASM/GSM
No
Market Lot
1
Fredun Pharmaceuticals Fundamentals
P/E Ratio
53.33
P/B Ratio
7.67
Div. Yield
0.02
Sector P/E
37.75
Sector P/B
3.16
Sec. Div. Yield
0.54
Fredun Pharmaceuticals Resistance and Support
Pivot 1381.4
Resistance
First Resistance
1409.6
Second Resistance
1428.2
Third Resistance
1456.4
Support
First Support
1362.8
Second Support
1334.6
Third Support
1316
Fredun Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Oct 23 2026 | 1398.9 | 1368.4 | -1.62% | 1398.9 | 1315.8 |
| Thu Oct 22 2026 | 1353.19 | 1391 | 1.84% | 1400 | 1353.19 |
| Wed Oct 21 2026 | 1436.9 | 1365.9 | -5.04% | 1450.3 | 1329.9 |
Fredun Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2025-09-25 | Preferential Issue of shares & Others |
| 2026-08-05 | Quarterly Results |
| 2026-05-25 | Audited Results |
| 2026-02-09 | Quarterly Results |
| 2025-11-08 | Quarterly Results |
| 2025-07-30 | Quarterly Results |
| 2025-05-30 | Audited Results & Dividend |
| 2025-02-04 | Quarterly Results |
| 2024-10-26 | Quarterly Results |
| 2024-10-03 | Others |
| 2024-07-29 | Quarterly Results |
Fredun Pharmaceuticals News
Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Allotment
Fredun Pharmaceuticals allotted 44,000 equity shares upon the conversion of 14,667 warrants by non-promoter investors. The allotment follows the payment of the balance consideration and incorporates adjustments from the recent 1:2 bonus issue.
Oct 23 2026 18:30:17
Fredun Pharmaceuticals Ltd - 539730 - Board Meeting Outcome for Outcome Of Board Meeting Dated 23Rd October, 2026
Fredun Pharmaceuticals allotted 44,000 equity shares to non-promoters on October 23, 2026. The shares were issued upon the conversion of 14,667 outstanding warrants, adjusted for the recent 1:2 bonus issue.
Oct 23 2026 18:26:58
Read More
Fredun Pharmaceuticals Management
| Name | Position |
|---|---|
| Daisy Dsouza | Non Executive Independent Director |
| Sonal Desai | Non Executive Independent Director |
Fredun Pharmaceuticals Similar Stocks
Shukra Medtech Ltd.
64.46
1.93 (3.09%)
Ind-Swift Laboratories Ltd.
327.45
-17.90 (5.18%)
Advanced Enzyme Technologies Ltd.
248.35
-10.50 (4.06%)
Hikal Ltd.
193.65
-9.53 (4.69%)
Dr Agarwals Eye Hospital Ltd.
5055.50
96.50 (1.95%)
Dishman Carbogen Amcis Ltd.
136.28
-3.74 (2.67%)
Indoco Remedies Ltd.
226.50
0.90 (0.40%)
Panacea Biotec Ltd.
311.45
-15.35 (4.70%)
Syncom Formulations (India) Ltd.
21.19
-0.89 (4.03%)
Sai Parenteral's Ltd.
461.70
10.20 (2.26%)
Fredun Pharmaceuticals FAQs
The Buying Price of Fredun Pharmaceuticals share is 1368.4 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Fredun Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Fredun Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Fredun Pharmaceuticals shares is 53.33. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Fredun Pharmaceuticals shares is 7.67. Useful to assess the stock's value relative to its book value.
To assess Fredun Pharmaceuticals’s valuation compare Sector P/E, P/B which are 37.75 & 3.16 with sector averages, along with growth rates and financial metrics.
The Market Cap of Fredun Pharmaceuticals is 2263.07 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Fredun Pharmaceuticals share price is 1665.00 & 1195.20. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Fredun Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in FREDUN
